Reuters - Genentech Inc. on Tuesday
reported that fourth-quarter profit rose 64 percent on
continued surging sales of its breast cancer drug Herceptin and
other cancer medicines.
View the entire article:
Cancer drug sales lift Genentech quarterly profit (Reuters)